Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase.

Yanase M, Ikeda H, Matsui A, Maekawa H, Noiri E, Tomiya T, Arai M, Yano T, Shibata M, Ikebe M, Fujiwara K, Rojkind M, Ogata I.

Biochem Biophys Res Commun. 2000 Oct 14;277(1):72-8.

PMID:
11027642
2.

Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.

Matsumoto Y, Tanaka K, Harimaya K, Nakatani F, Matsuda S, Iwamoto Y.

Jpn J Cancer Res. 2001 Apr;92(4):429-38.

PMID:
11346466
3.
4.

Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.

Sawada K, Morishige Ki, Tahara M, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y.

Gynecol Oncol. 2002 Dec;87(3):252-9.

PMID:
12468322
5.

A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth.

Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H.

J Hepatol. 2000 May;32(5):762-70.

PMID:
10845663
7.

Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction.

van Nieuw Amerongen GP, Vermeer MA, van Hinsbergh VW.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):E127-33.

8.

Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells.

Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S, Fujiwara K.

Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G880-6. Epub 2003 Jun 26.

9.

Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway.

Ji H, Meng Y, Zhang X, Luo W, Wu P, Xiao B, Zhang Z, Li X.

Regul Pept. 2011 Aug 8;169(1-3):13-20. doi: 10.1016/j.regpep.2011.04.010. Epub 2011 May 3.

PMID:
21545816
10.

Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.

Iizuka M, Murata T, Hori M, Ozaki H.

Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1010-21. doi: 10.1152/ajpgi.00350.2010. Epub 2011 Mar 10.

11.

Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.

Rao PV, Deng PF, Kumar J, Epstein DL.

Invest Ophthalmol Vis Sci. 2001 Apr;42(5):1029-37. Erratum in: Invest Ophthalmol Vis Sci 2001 Jul;42(8):1690.

PMID:
11274082
12.

Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line.

Yanase M, Ikeda H, Ogata I, Matsui A, Noiri E, Tomiya T, Arai M, Inoue Y, Tejima K, Nagashima K, Nishikawa T, Shibata M, Ikebe M, Rojkind M, Fujiwara K.

Biochem Biophys Res Commun. 2003 May 30;305(2):223-8.

PMID:
12745062
13.
14.
15.

Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis.

Cho MK, Lee GH, Park EY, Kim SG.

Tissue Cell. 2004 Oct;36(5):293-305.

PMID:
15385147
16.
17.
18.

Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.

Takeda H, Matozaki T, Fujioka Y, Takada T, Noguchi T, Yamao T, Tsuda M, Ochi F, Fukunaga K, Narumiya S, Yamamoto T, Kasuga M.

Oncogene. 1998 Jun 11;16(23):3019-27.

19.

Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase.

Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K.

Science. 1997 Feb 28;275(5304):1308-11.

20.

Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.

Izawa I, Amano M, Chihara K, Yamamoto T, Kaibuchi K.

Oncogene. 1998 Dec 3;17(22):2863-71.

Items per page

Supplemental Content

Write to the Help Desk